Skip to main content
. 2023 Jan 25;40(3):537–552. doi: 10.1007/s10815-023-02724-z

Table 1.

Clinical characteristics of PCOS and control subjects

Project C1 C2 C3 P1 P2 P3 p value
Age (years) 28.5 27.3 29.2 25.3 26. 5 28.6 0.240209
BMI (kg/m2) 23.3 24.9 22.0 19.9 23.0 24.7 0.624407
LH (IU/L) 6.1 8.1 5.1 10.1 12.3 14.9 0.0217718
FSH (IU/L) 7.0 6.0 7.8 6.4 6.0 5.1 0.164435
E2 (pmol/L) 119.7 106.3 132.5 168.6 158.3 159.6 0.00658136
T (nmol/L) 1.0 0.5 1.3 3.5 2.9 2.3 0.0092485
FBG (mmol/L) 5.1 5.2 5.0 5.0 5.2 5.3 0.561437
Infertility (years) 3.9 3.6 4.1 2.9 2.6 3.5 0.0454128
PRL (ng/mL) 19.8 25.3 15.4 31.6 36.5 42.9 0.0179693
AMH (ng/mL) 4.1 5.6 6.8 9.2 11.9 13.5 0.0150721
Number of follicles 12 11 12 22 22 21 <0.0001

BMI, body mass index; LH, luteinizing hormone; FSH, follicle-stimulating hormone; E2, estradiol; T, testosterone; FBG, fasting blood glucose; PRL, prolactin; AMH, anti-Müllerian hormone. The bold numbers indicate statistically significant values